NS
Article DetailSEC EDGAR Filings
首页文档检索台
SEC EDGAR Filings

8-K - NEKTAR THERAPEUTICS - 7.01 / 8.01 / 9.01

Filed: 2026-04-20 AccNo: 0001193125-26-162763 Size: 16 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
查看原文来源主页查看事件簇按来源查看
发布时间04/20 12:02 UTC
首次发现04/20 12:06 UTC
热度105.2
重要度64
情绪0.00

站内整理正文

优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 652 字符

Form 8-K - Current report: SEC Accession No. 0001193125-26-162763

Filing Date: 2026-04-20

Accepted: 2026-04-20 08:02:01

Documents: 50

Period of Report: 2026-04-20

Items: Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

NEKTAR THERAPEUTICS (Filer) CIK : 0000906709 (see all company filings) EIN. : 943134940 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | 8-K | d25375d8k.htm iXBRL | 8-K

2 | EX-99.1 | d25375dex991.htm | EX-99.1

3 | EX-99.2 | d25375dex992.htm | EX-99.2

7 | GRAPHIC | g25375ex99_2p10g1.jpg | GRAPHIC